Correlation Between Pfizer and Peyto ExplorationDevel
Can any of the company-specific risk be diversified away by investing in both Pfizer and Peyto ExplorationDevel at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Peyto ExplorationDevel into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Peyto ExplorationDevelopment Corp, you can compare the effects of market volatilities on Pfizer and Peyto ExplorationDevel and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Peyto ExplorationDevel. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Peyto ExplorationDevel.
Diversification Opportunities for Pfizer and Peyto ExplorationDevel
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pfizer and Peyto is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Peyto ExplorationDevelopment C in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Peyto ExplorationDevel and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Peyto ExplorationDevel. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Peyto ExplorationDevel has no effect on the direction of Pfizer i.e., Pfizer and Peyto ExplorationDevel go up and down completely randomly.
Pair Corralation between Pfizer and Peyto ExplorationDevel
Considering the 90-day investment horizon Pfizer is expected to generate 2.51 times less return on investment than Peyto ExplorationDevel. But when comparing it to its historical volatility, Pfizer Inc is 1.11 times less risky than Peyto ExplorationDevel. It trades about 0.02 of its potential returns per unit of risk. Peyto ExplorationDevelopment Corp is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 1,020 in Peyto ExplorationDevelopment Corp on September 1, 2024 and sell it today you would earn a total of 165.00 from holding Peyto ExplorationDevelopment Corp or generate 16.18% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. Peyto ExplorationDevelopment C
Performance |
| Timeline |
| Pfizer Inc |
| Peyto ExplorationDevel |
Pfizer and Peyto ExplorationDevel Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and Peyto ExplorationDevel
The main advantage of trading using opposite Pfizer and Peyto ExplorationDevel positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Peyto ExplorationDevel can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Peyto ExplorationDevel will offset losses from the drop in Peyto ExplorationDevel's long position.| Pfizer vs. Crinetics Pharmaceuticals | Pfizer vs. Enanta Pharmaceuticals | Pfizer vs. Amicus Therapeutics | Pfizer vs. Connect Biopharma Holdings |
| Peyto ExplorationDevel vs. Birchcliff Energy | Peyto ExplorationDevel vs. Tamarack Valley Energy | Peyto ExplorationDevel vs. Gear Energy | Peyto ExplorationDevel vs. Spartan Delta Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |